Literature DB >> 17705402

Unusual regioselectivity and active site topology of human cytochrome P450 2J2.

Pierre Lafite1, François André, Darryl C Zeldin, Patrick M Dansette, Daniel Mansuy.   

Abstract

The oxidation of six derivatives of terfenadone by recombinant human CYP2J2 (CYP = cytochrome P450) was studied by high-performance liquid chromatography coupled to mass spectrometry (MS) using tandem MS techniques and by 1H NMR spectroscopy. CYP2J2 exhibited a surprising regioselectivity in favor of the hydroxylation of the substrate terminal chain at the weakly reactive homobenzylic position. In contrast, hydroxylation of the same substrates by CYP3A4 mainly occurred on the most chemically reactive sites of the substrates (N-oxidation and benzylic hydroxylation). A 3D homology model of CYP2J2 was constructed using recently published structures of CYP2A6, CYP2B4, CYP2C8, CYP2C9, and CYP2D6 as templates. In contrast with other CYP2 structures, it revealed an active site cavity with a severely restricted access of substrates to the heme through a narrow hydrophobic channel. Dynamic docking of terfenadone derivatives in the CYP2J2 active site allowed one to interpret the unexpected regioselectivity of the hydroxylation of these substrates by CYP2J2, which is mainly based on this restricted access to the iron. The structural features that have been found to be important for recognition of substrates or inhibitors by CYP2J2 were also interpreted on the basis of CYP2J2-substrate interactions in this model.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17705402      PMCID: PMC2377029          DOI: 10.1021/bi700876a

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  52 in total

1.  Involvement of CYP2J2 and CYP4F12 in the metabolism of ebastine in human intestinal microsomes.

Authors:  Takanori Hashizume; Susumu Imaoka; Masashi Mise; Yoshiaki Terauchi; Toshihiko Fujii; Hisashi Miyazaki; Tetsuya Kamataki; Yoshihiko Funae
Journal:  J Pharmacol Exp Ther       Date:  2002-01       Impact factor: 4.030

2.  Use of molecular simulation for mapping conformational CYP2E1 epitopes.

Authors:  Matteo Vidali; Mats Hidestrand; Erik Eliasson; Elisa Mottaran; Emanuela Reale; Roberta Rolla; Giuseppa Occhino; Emanuele Albano; Magnus Ingelman-Sundberg
Journal:  J Biol Chem       Date:  2004-09-28       Impact factor: 5.157

3.  CYP2E1 active site residues in substrate recognition sequence 5 identified by photoaffinity labeling and homology modeling.

Authors:  Samuel L Collom; Arvind P Jamakhandi; Alan J Tackett; Anna Radominska-Pandya; Grover P Miller
Journal:  Arch Biochem Biophys       Date:  2006-11-02       Impact factor: 4.013

4.  Structure of microsomal cytochrome P450 2B4 complexed with the antifungal drug bifonazole: insight into P450 conformational plasticity and membrane interaction.

Authors:  Yonghong Zhao; Mark A White; B K Muralidhara; Ling Sun; James R Halpert; C David Stout
Journal:  J Biol Chem       Date:  2005-12-21       Impact factor: 5.157

5.  Regioselectivity of CYP2B6: homology modeling, molecular dynamics simulation, docking.

Authors:  Christine Bathelt; Rolf D Schmid; Jürgen Pleiss
Journal:  J Mol Model       Date:  2002-11-15       Impact factor: 1.810

6.  Characterization of ebastine, hydroxyebastine, and carebastine metabolism by human liver microsomes and expressed cytochrome P450 enzymes: major roles for CYP2J2 and CYP3A.

Authors:  Kwang-Hyeon Liu; Mi-Gyung Kim; Dong-Jun Lee; Yune-Jung Yoon; Min-Jung Kim; Ji-Hong Shon; Chang Soo Choi; Young Kil Choi; Zeuresenay Desta; Jae-Gook Shin
Journal:  Drug Metab Dispos       Date:  2006-08-08       Impact factor: 3.922

7.  Hepatic epoxide hydrase. Structure-activity relationships for substrates and inhibitors.

Authors:  F Oesch; N Kaubisch; D M Jerina; J W Daly
Journal:  Biochemistry       Date:  1971-12-21       Impact factor: 3.162

8.  Cytochrome P450-mediated oxidation of glucuronide derivatives: example of estradiol-17beta-glucuronide oxidation to 2-hydroxy-estradiol-17beta-glucuronide by CYP 2C8.

Authors:  M Delaforge; A Pruvost; L Perrin; F André
Journal:  Drug Metab Dispos       Date:  2004-12-17       Impact factor: 3.922

9.  Enhancement of cardiac L-type Ca2+ currents in transgenic mice with cardiac-specific overexpression of CYP2J2.

Authors:  Yong-Fu Xiao; Qingen Ke; John M Seubert; J Alyce Bradbury; Joan Graves; Laura M Degraff; John R Falck; Kris Krausz; Harry V Gelboin; James P Morgan; Darryl C Zeldin
Journal:  Mol Pharmacol       Date:  2004-09-10       Impact factor: 4.436

10.  Structures of human microsomal cytochrome P450 2A6 complexed with coumarin and methoxsalen.

Authors:  Jason K Yano; Mei-Hui Hsu; Keith J Griffin; C David Stout; Eric F Johnson
Journal:  Nat Struct Mol Biol       Date:  2005-08-07       Impact factor: 15.369

View more
  16 in total

Review 1.  Structural control of cytochrome P450-catalyzed ω-hydroxylation.

Authors:  Jonathan B Johnston; Hugues Ouellet; Larissa M Podust; Paul R Ortiz de Montellano
Journal:  Arch Biochem Biophys       Date:  2010-08-19       Impact factor: 4.013

Review 2.  Cytochrome P450 2U1, a very peculiar member of the human P450s family.

Authors:  L Dhers; L Ducassou; J-L Boucher; D Mansuy
Journal:  Cell Mol Life Sci       Date:  2017-01-12       Impact factor: 9.261

3.  The Structure of Mycobacterium tuberculosis CYP125: molecular basis for cholesterol binding in a P450 needed for host infection.

Authors:  Kirsty J McLean; Pierre Lafite; Colin Levy; Myles R Cheesman; Natalia Mast; Irina A Pikuleva; David Leys; Andrew W Munro
Journal:  J Biol Chem       Date:  2009-12-18       Impact factor: 5.157

4.  Arachidonic Acid Metabolism by Human Cardiovascular CYP2J2 Is Modulated by Doxorubicin.

Authors:  William R Arnold; Javier L Baylon; Emad Tajkhorshid; Aditi Das
Journal:  Biochemistry       Date:  2017-12-12       Impact factor: 3.162

5.  Computational modelling of the binding of arachidonic acid to the human monooxygenase CYP2J2.

Authors:  G Proietti; K K Abelak; D Bishop-Bailey; A Macchiarulo; I Nobeli
Journal:  J Mol Model       Date:  2016-10-28       Impact factor: 1.810

6.  Heme Modification Contributes to the Mechanism-Based Inactivation of Human Cytochrome P450 2J2 by Two Terminal Acetylenic Compounds.

Authors:  Hsia-Lien Lin; Haoming Zhang; Vyvyca J Walker; Jaime D'Agostino; Paul F Hollenberg
Journal:  Drug Metab Dispos       Date:  2017-07-11       Impact factor: 3.922

7.  Endocannabinoids anandamide and 2-arachidonoylglycerol are substrates for human CYP2J2 epoxygenase.

Authors:  Daniel R McDougle; Amogh Kambalyal; Daryl D Meling; Aditi Das
Journal:  J Pharmacol Exp Ther       Date:  2014-10-02       Impact factor: 4.030

8.  Structural basis for cooperative binding of azoles to CYP2E1 as interpreted through guided molecular dynamics simulations.

Authors:  Joseph W Levy; Jessica H Hartman; Martin D Perry; Grover P Miller
Journal:  J Mol Graph Model       Date:  2014-12-06       Impact factor: 2.518

9.  Incorporation of charged residues in the CYP2J2 F-G loop disrupts CYP2J2-lipid bilayer interactions.

Authors:  Daniel R McDougle; Javier L Baylon; Daryl D Meling; Amogh Kambalyal; Yelena V Grinkova; Jared Hammernik; Emad Tajkhorshid; Aditi Das
Journal:  Biochim Biophys Acta       Date:  2015-07-30

10.  Structural and biochemical characterization of Mycobacterium tuberculosis CYP142: evidence for multiple cholesterol 27-hydroxylase activities in a human pathogen.

Authors:  Max D Driscoll; Kirsty J McLean; Colin Levy; Natalia Mast; Irina A Pikuleva; Pierre Lafite; Stephen E J Rigby; David Leys; Andrew W Munro
Journal:  J Biol Chem       Date:  2010-09-30       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.